Treatment of cultured glioma cells with the EGFR-TKI gefitinib ("Iressa", ZD1839) increases the uptake of astatinated EGF despite the absence of gefitinib-mediated growth inhibition.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples